Globally, rotavirus remains the leading cause of diarrheal deaths in children under five years old. In the Philippines, 6,500 cases
We are pleased to announce the successful completion of the Good Manufacturing Practice (GMP) inspection conducted by the Philippine Food
Faberco is proud to announce its recent partnership with Sinovac, a global leader in biopharmaceuticals. We seek partnerships with companies
The Philippine FDA has approved the product registration for Mylan HIV Self-Test kit and Faberco Life Sciences, Inc. is the
Faberco Life Sciences is proud to announce that our Regulatory Affairs team actively participated in the Philippine Pharmacists Association Inc.
At Faberco, we are steadfast in our commitment to supporting the global fight against HIV and achieving the 95-95-95 goals.
The Health Technology Assessment Committee (HTAC), an independent advisory body created under the Universal Health Care Act provides guidance to
The Philippine Food and Drug Administration has given an Emergency Use Authorization (EUA) for COVID-19 treatment pill Molnupiravir (under the
Faberco Life Sciences, Inc. turn over today, November 23, 2021, the first batch of MOLNUPIRAVIR (Molnarz™) to the City of
Globally, rotavirus remains the leading cause of diarrheal deaths in children under five years old. In the Philippines, 6,500 cases
We are pleased to announce the successful completion of the Good Manufacturing Practice (GMP) inspection conducted by the Philippine Food
Faberco is proud to announce its recent partnership with Sinovac, a global leader in biopharmaceuticals. We seek partnerships with companies
The Philippine FDA has approved the product registration for Mylan HIV Self-Test kit and Faberco Life Sciences, Inc. is the
Faberco Life Sciences is proud to announce that our Regulatory Affairs team actively participated in the Philippine Pharmacists Association Inc.
At Faberco, we are steadfast in our commitment to supporting the global fight against HIV and achieving the 95-95-95 goals.
The Health Technology Assessment Committee (HTAC), an independent advisory body created under the Universal Health Care Act provides guidance to
The Philippine Food and Drug Administration has given an Emergency Use Authorization (EUA) for COVID-19 treatment pill Molnupiravir (under the
